专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

51. 发明申请

WO2009008966A1 ROUTING PROTOCOL FOR A NETWORK EMPLOYING MULTI-USER WIRELESS CHANNELS 审中-公开
标题翻译：使用多用户无线通道的网络路由协议
公开(公告)号：WO2009008966A1
公开(公告)日：2009-01-15
申请号：PCT/US2008/008029
申请日：2008-06-26
申请人： LUCENT TECHNOLOGIES INC. , LI, Li , RAMJEE, Ramachandran , VISWANATHAN, Harish
发明人： LI, Li , RAMJEE, Ramachandran , VISWANATHAN, Harish
IPC分类号： H04L12/56
CPC分类号： H04W40/02 , H04L1/0002 , H04L1/0057 , H04L45/125 , H04W40/34 , H04W72/1263 , Y02D70/142 , Y02D70/22 , Y02D70/30
摘要： A routing protocol, according to one embodiment of which a first station of a wireless network monitors its outgoing transmissions corresponding to a traffic flow for occurrence of multi-tier signals and for ability to achieve a specified minimum transmission rate. Based on the monitoring, the first station may transmit an outgoing solicitation message that identifies the monitored traffic flow as a candidate for rerouting. Upon receipt of the solicitation message, a second station of the wireless network evaluates whether rerouting of the monitored traffic flow through the second station is capable of increasing data throughput for that traffic flow without decreasing data throughputs for other traffic flows presently handled by the second station. Based on this evaluation, the second station may transmit to the first station an offer to reroute the monitored traffic flow. The first station, in turn, evaluates this offer, e.g., by comparing its benefits with those of alternative offers that the first station might have received from other stations of the wireless network in response to the solicitation message. Based on the latter evaluation, the first station may reroute the monitored traffic flow through the station whose offer is deemed preferable.
摘要翻译：根据一个实施例的路由协议，无线网络的第一站监视其对应于业务流的出局传输以发生多层信号，并且能够实现指定的最小传输速率。基于监视，第一站可以将识别被监视的业务流的传出请求消息作为重新路由的候选者发送。在接收到请求消息时，无线网络的第二站评估通过第二站的所监视的业务流的重新路由是否能够增加该业务流的数据吞吐量，而不减少目前由第二站处理的其他业务流的数据吞吐量。基于该评估，第二站可以向第一站发送重新路由所监视的业务流的报价。反过来，第一站又通过将其优点与第一站可能响应于该请求消息从无线网络的其他站接收到的替代提供的优点进行比较来评估该提供。基于后一种评估，第一站可以将监视的业务流重新路由通过被认为优选的站。

52. 发明申请

WO2009008960A1 MEDIA-ACCESS-CONTROL PROTOCOL FOR A NETWORK EMPLOYING MULTI-USER WIRELESS CHANNELS 审中-公开
标题翻译：使用多用户无线通道的网络的媒体访问控制协议
公开(公告)号：WO2009008960A1
公开(公告)日：2009-01-15
申请号：PCT/US2008/007952
申请日：2008-06-26
申请人： LUCENT TECHNOLOGIES INC. , LI, Li , RAMJEE, Ramachandran , VISWANATHAN, Harish
发明人： LI, Li , RAMJEE, Ramachandran , VISWANATHAN, Harish
IPC分类号： H04L12/56
CPC分类号： H04W40/02 , H04L1/0002 , H04L1/0057 , H04L45/125 , H04W40/34 , H04W72/1263 , Y02D70/142 , Y02D70/22 , Y02D70/30
摘要： A medium-access-control (MAC) scheduler, according to one embodiment of which a station of a wireless network evaluates data throughputs corresponding to three different transmission configurations for transmission of a packet over a first of that station's wireless links. The first and second of those transmission configurations have the packet encoded in the first and second tiers, respectively, of a two-tier signal. The third transmission configuration has the packet encoded as a conventional single-tier signal. For each of the first and second transmission configurations, the station selects a second of that station's wireless links for transmission of at least a second packet, with the first and second packets encoded in different respective tiers of the two-tier signal. The station varies power allocation between the first and second tiers to optimize data throughput for each of the first and second transmission configurations and selects from the first, second, and third transmission configurations one resulting in the highest data throughput.
摘要翻译：媒体访问控制（MAC）调度器，根据其一个实施例，无线网络的站评估对应于三个不同传输配置的数据吞吐量，以在该站的无线链路上的第一个无线链路上传输分组。这些传输配置中的第一和第二配置分别在两层信号的第一和第二层中编码分组。第三传输配置将分组编码为传统的单层信号。对于第一和第二传输配置中的每一个，站选择该站的无线链路中的第二个用于传输至少第二分组，其中第一和第二分组被编码在两层信号的不同相应层中。该站改变第一和第二层之间的功率分配，以优化第一和第二传输配置中的每一个的数据吞吐量，并从第一，第二和第三传输配置中选择一个导致最高数据吞吐量。

53. 发明申请

WO2008063135A1 APPARATUS FOR PROCESSING A SAMPLE IN A LIQUID DROPLET AND METHOD OF USING THE SAME 审中-公开
标题翻译：用于处理液体滴液中的样品的装置及其使用方法
公开(公告)号：WO2008063135A1
公开(公告)日：2008-05-29
申请号：PCT/SG2006/000363
申请日：2006-11-24
申请人： AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH , LECK, Kwong Joo , KIM, Nam Yong , YING, Y. Jackie , LI, Li , LEE, Yong Yeow
发明人： LECK, Kwong Joo , KIM, Nam Yong , YING, Y. Jackie , LI, Li , LEE, Yong Yeow
IPC分类号： G01N31/20 , G01N1/28 , G01N33/48
CPC分类号： G01N1/31 , B01L3/5088 , B01L2300/0609 , B01L2300/0829 , B01L2300/089 , B01L2300/161 , B01L2400/0415 , C12M25/01 , G01N33/54373 , G01N2035/1037
摘要： An apparatus and method for processing samples in a liquid droplet comprising a processing reservoir and immobilisation member (2). The reservoir contains a medium (8) which is immiscible with the liquid droplet and having a lower surface energy than the liquid droplet. The immobilisation member is contained in the reservoir and comprises a patterned surface (7) so as to immobilise the droplet and having a higher surface energy than the surrounding area and a sufficient width to allow immobilization of the droplet due to hydrophilic/phobic interactions.
摘要翻译：一种用于处理液滴中的样品的装置和方法，包括处理容器和固定构件（2）。储存器包含与液滴不混溶并且具有比液滴低的表面能的介质（8）。固定构件包含在储存器中并且包括图案化表面（7），以便固定液滴并具有比周围区域更高的表面能，并具有足够的宽度以允许由于亲水/疏水相互作用而使液滴固定。

54. 发明申请

WO2008042131A1 SYSTEM AND METHOD FOR DISPLAY CONTROL OF PATIENT MONITOR 审中-公开
标题翻译：用于显示患者监护仪的系统和方法
公开(公告)号：WO2008042131A1
公开(公告)日：2008-04-10
申请号：PCT/US2007/020536
申请日：2007-09-21
申请人： NELLCOR PURITAN BENNETT LLC , BOYCE, Robin, S. , WANG, Hui , AMUNDSON, Scott , LI, Li , MADERE, Tonia , OCHS, James , VARGAS, Steve
发明人： BOYCE, Robin, S. , WANG, Hui , AMUNDSON, Scott , LI, Li , MADERE, Tonia , OCHS, James , VARGAS, Steve
IPC分类号： G06F19/00 , A61B5/00
CPC分类号： G06F19/3418 , A61B5/02055 , A61B5/0255 , A61B5/145 , A61B5/7445 , A61B5/7475 , G06F19/00 , G16H40/63 , G16H50/70
摘要： Embodiments of the present invention relate to monitoring systems. One embodiment includes a monitoring system comprising a monitor (10) configured to receive input relating to patient physiological parameters and to store historical data (108) related to the parameters. Further, the system comprises a screen (28) configured to display the historical data (108) corresponding to the patient physiological parameters, and a display control feature configured to automatically find and display an event in the historical data (108) on the screen (28) when the display control feature is activated.
摘要翻译：本发明的实施例涉及监视系统。一个实施例包括监视系统，其包括被配置为接收与患者生理参数相关的输入并且存储与参数相关的历史数据（108）的监视器（10）。此外，该系统包括被配置为显示对应于患者生理参数的历史数据（108）的屏幕（28），以及被配置为自动在屏幕上的历史数据（108）中查找和显示事件的显示控制特征（ 28）当显示控制功能被激活时。

55. 发明申请

WO2007146268A2 METHODS FOR REDUCING OR PREVENTING LIQUID-LIQUID PHASE SEPARATION IN HIGH CONCENTRATION PROTEIN SALUTIONS 审中-公开
标题翻译：降低或预防高浓度蛋白质中液相液相分离的方法
公开(公告)号：WO2007146268A2
公开(公告)日：2007-12-21
申请号：PCT/US2007/013747
申请日：2007-06-12
申请人： WYETH , LI, Li , KANTOR, Angela , WARNE, Nicholas, W.
发明人： LI, Li , KANTOR, Angela , WARNE, Nicholas, W.
IPC分类号： G01N33/50
CPC分类号： C07K1/36
摘要： Methods of formulating proteins at high concentrations in protein solutions, wherein the protein solutions lack or have reduced liquid-liquid phase separation are described. Such protein solutions are substantially clear and substantially homogenous. Additionally, methods of concentrating and purifying proteins using liquid-liquid phase separation are provided.
摘要翻译：在蛋白质溶液中配制高浓度蛋白质的方法，其中蛋白质溶液缺乏或液 - 液相分离减少。这种蛋白质溶液基本上是清楚的并且基本上均匀。另外，提供了使用液 - 液相分离来浓缩和纯化蛋白质的方法。

56. 发明申请

WO2007041334A1 SYSTEM AND METHOD FOR REMOVING ARTIFACTS FROM WAVEFORMS 审中-公开
标题翻译：从波形去除人造物的系统和方法
公开(公告)号：WO2007041334A1
公开(公告)日：2007-04-12
申请号：PCT/US2006/038125
申请日：2006-09-29
申请人： NELLCOR PURITAN BENNETT INCORPORATED , LI, Li , MANNHEIMER, Paul
发明人： LI, Li , MANNHEIMER, Paul
IPC分类号： G06K9/00
CPC分类号： A61B5/7207 , A61B5/02416 , A61B5/14551 , A61B5/4875 , G06K9/00516
摘要： A technique is provided for processing a physiological signal to compensate for artifacts. The technique includes identifying artifacts within the physiological signal. The technique also includes performing one or more multi-resolution decompositions, such as wavelet transformations, on the physiological signal and compensating for the identified artifacts in some or all of the respective decomposition components. The modified decomposition components may be reconstructed to generate an artifact-compensated signal which may be provided to a monitor or other device which is otherwise not configured to compensate for signal artifacts.
摘要翻译：提供了一种用于处理生理信号以补偿伪影的技术。该技术包括识别生理信号内的伪影。该技术还包括在生理信号上执行一个或多个多分辨率分解，例如小波变换，并补偿部分或全部相应的分解分量中所识别的人为因素。经修改的分解分量可被重建以产生伪影补偿信号，该信号可被提供给监视器或其他未被配置为补偿信号伪影的其他设备。

57. 发明申请

WO2006138218A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：联苯化合物有效作为MUSCARINIC受体拮抗剂
公开(公告)号：WO2006138218A1
公开(公告)日：2006-12-28
申请号：PCT/US2006/022829
申请日：2006-06-12
申请人： THERAVANCE, INC. , JI, Yu-Hua , MAMMEN, Mathai , HUSFELD, Craig , LI, Li , MU, YongQi , KUSHNER, Aaron , STANGELAND, Eric L. , MISCHKI, Trevor , HUGHES, Adam , DUNHAM, Sarah
发明人： JI, Yu-Hua , MAMMEN, Mathai , HUSFELD, Craig , LI, Li , MU, YongQi , KUSHNER, Aaron , STANGELAND, Eric L. , MISCHKI, Trevor , HUGHES, Adam , DUNHAM, Sarah
IPC分类号： C07D211/46 , C07D405/12 , C07D401/12 , C07D409/12 , C07D487/08 , A61K31/445 , A61P11/00 , A61P11/08 , A61P11/06
CPC分类号： C07D211/46 , C07D405/12 , C07D409/12 , C07D487/08
摘要： The invention provides compounds of formula (I) wherein a, b, c, m, s, t, W, Z, Ar, R 1 , R 2 , R 3 , R 6 , and R 7 are as defined in the specification. The compounds of formula (I) are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
摘要翻译：本发明提供式（I）化合物，其中a，b，c，m，s，t，w，Z，Ar，R 1，R 2， SUP> 3，R 6和R 7如说明书中所定义。式（I）化合物是毒蕈碱受体拮抗剂。本发明还提供含有这些化合物的药物组合物，用于制备这些化合物的方法和中间体以及使用这些化合物治疗肺部疾病的方法。

58. 发明申请

WO2006105538A2 METHODS AND COMPOSITIONS FOR TREATING IL-21 RELATED PATHOLOGIES 审中-公开
标题翻译：用于治疗IL-21相关病理学的方法和组合物
公开(公告)号：WO2006105538A2
公开(公告)日：2006-10-05
申请号：PCT/US2006/012749
申请日：2006-03-31
申请人： CENTOCOR, INC. , MA, Keying , SONG, Xiao-yu , GRISWORLD, Donald, E. , SHANG, Xiaozhou , LI, Li
发明人： MA, Keying , SONG, Xiao-yu , GRISWORLD, Donald, E. , SHANG, Xiaozhou , LI, Li
IPC分类号： A61K39/395
CPC分类号： C07K16/244 , C07K2317/56 , C07K2317/74
摘要： The present invention relates to methods for treating at least one IL-21 related condition or pathology, including therapeutic compositions, methods and devices, wherein said patholog involves the increase in IgE production or IgE isotype switching.
摘要翻译：本发明涉及用于治疗至少一种IL-21相关病症或病理学的方法，包括治疗组合物，方法和装置，其中所述病理学包括增加IgE产生或IgE同种型转换。

59. 发明申请

WO2006099032A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS 审中-公开
标题翻译：联苯化合物有效作为MUSCARINIC受体拮抗剂
公开(公告)号：WO2006099032A1
公开(公告)日：2006-09-21
申请号：PCT/US2006/008393
申请日：2006-03-09
申请人： THERAVANCE, INC. , JI, Yu-Hua , HUSFELD, Craig , LI, Li , MAMMEN, Mathai , MU, YongQi , STANGELAND, Eric L.
发明人： JI, Yu-Hua , HUSFELD, Craig , LI, Li , MAMMEN, Mathai , MU, YongQi , STANGELAND, Eric L.
IPC分类号： C07D409/12 , C07D405/14 , C07D401/12 , C07D211/62 , A61K31/445 , A61K31/4525 , A61K31/4535 , A61K31/454 , A61K31/4545 , C07D401/14
CPC分类号： C07D405/14 , C07D211/62 , C07D401/12 , C07D409/14
摘要： The invention provides compounds of formula I: wherein a, b, c, d, n, R 1 , R 2 , R 3 , R 6 , R 7 , W, and A are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.
摘要翻译：本发明提供式I化合物：其中a，b，c，d，n，R 1，R 2，R 3，R 7，R 7，W和A如说明书中所定义。式I化合物是毒蕈碱受体拮抗剂。本发明还提供含有这些化合物的药物组合物，用于制备这些化合物的方法和中间体以及使用这些化合物治疗肺部疾病的方法。

60. 发明申请

WO2005123670A2 CRYSTALLINE FORM OF A SUBSTITUTED PYRROLIDINE COMPOUND 审中-公开
标题翻译：取代的吡咯烷酮化合物的结晶形式
公开(公告)号：WO2005123670A2
公开(公告)日：2005-12-29
申请号：PCT/US2005/020282
申请日：2005-06-09
申请人： THERAVANCE, INC. , LI, Li , CHAO, Robert S. , HUGHES, Adam , JI, Yu-Hua , KHOSSRAVI, Davar , ZHANG, Weijiang
发明人： LI, Li , CHAO, Robert S. , HUGHES, Adam , JI, Yu-Hua , KHOSSRAVI, Davar , ZHANG, Weijiang
IPC分类号： C07D207/09
CPC分类号： C07D207/09
摘要： The invention provides a crystalline naphthalene-1,5-disulfonic acid salt of 2-[(S)-1-(8-methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide or a solvate thereof. This invention also provides pharmaceutical compositions comprising the salt or prepared using the salt; processes and intermediates for preparing the salt; and methods of using the salt to treat a pulmonary disorder.
摘要翻译：本发明提供2 - [（S）-1-（8-甲基氨基辛基）吡咯烷-3-基] -2,2-二苯基乙酰胺或其溶剂合物的结晶萘-1,5-二磺酸盐。本发明还提供了包含该盐或使用该盐制备的药物组合物; 制备盐的方法和中间体; 以及使用盐治疗肺部疾病的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式